Messenger RNA technology made it possible for scientists and drugmakers to quickly develop a Covid-19 vaccine.

Now, pharmaceutical companies are racing to use mRNA for other illnesses, including flu, cancer and rare genetic diseases. 

Dr. Drew Weissman, one of the researchers who pioneered the mRNA technology that led to the Covid vaccine, joins this episode to talk about his discovery, and the impact it will continue to have on the way patients are treated. Bloomberg’s biosecurity reporter Riley Griffin stops in to discuss Pfizer’s next phase of developing mRNA vaccines. And Bloomberg’s chief medical writer Robert Langreth forecasts how this technology could transform treatment for a variety of illnesses.

Learn more about this story here: https://bloom.bg/3fm3Bt8

Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK 

Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.